Elisa/Act Biotechnologies, based in Sterling, VA, is a leading provider of advanced clinical testing services for identifying hidden causes of various health concerns. Their revolutionary LRA tests directly analyze lymphocytes to help physicians determine food and chemical hypersensitivities, providing accurate and comprehensive insights for personalized treatment plans.
Founded by Dr. Russell M. Jaffe, Elisa/Act Biotechnologies offers predictive biomarker testing and nutritional consultations to support patients in achieving optimal health and resilience. With a focus on evidence-based solutions and documented clinical successes, their services have been instrumental in helping individuals address chronic conditions and improve their overall well-being.
Generated from the website